BLTE Belite Bio, Inc.

Fundamentals / CIK 0001889109 / USD

Belite Bio, Inc. reported $780.6M in total assets and a net loss of $77.61M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BLTE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$72.57MFY 2020 Net Income: -$5.75M2020FY 2021 Net Income: -$9.67M2021FY 2022 Net Income: -$12.65M2022FY 2023 Net Income: -$31.63M2023FY 2024 Net Income: -$36.14M2024FY 2025 Net Income: -$77.61M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $45.38M $29.94M $24.84M $8.87M $7.42M $3.69M
Selling, General & Admin $38.83M $10.06M $6.82M -- -- --
Total Operating Expenses $84.21M $40.00M $31.67M $12.82M $9.80M $5.74M
Operating Income -$84.21M -$40.00M -$31.67M -$12.82M -$9.80M -$5.74M
EBITDA -$84.02M -$39.83M -$31.53M -$12.76M -$9.77M -$5.73M
Interest Income $6.64M $3.74M $74K $23K $5.0K $12K
Interest Expense $2.0K $20K $25K $16K -- $21K
Income Before Tax -$77.61M -$36.14M -$31.62M -$12.65M -$9.67M -$5.75M
Income Tax Expense $0 $6.0K $9.0K -- -- $1.0K
Net Income -$77.61M -$36.14M -$31.63M -$12.65M -$9.67M -$5.75M
Basic EPS -$2.31 -$1.18 -$1.19 -$0.63 -$1.01 -$0.65
Diluted EPS -$2.31 -$1.18 -$1.19 -$0.63 -$1.01 -$0.65
Basic Shares Outstanding 33.5M 30.5M 26.6M 20.0M 9.6M 8.8M
Diluted Shares Outstanding 33.5M 30.5M 26.6M 20.0M 9.6M 8.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for BLTE.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $352.9M $31.68M $88.16M $42.09M $17.34M
Short-Term Investments -- $4.55M -- -- --
Cash & Short-Term Investments $352.9M $36.23M $88.16M $42.09M $17.34M
Other Current Assets $5.0K -- -- -- --
Total Current Assets $494.3M $147.1M $89.94M $42.81M $17.43M
Property, Plant & Equipment, Net $344K $444K $490K $541K $94K
Intangible Assets $19K $31K -- -- --
Total Non-Current Assets $286.3M $5.06M $4.70M $1.47M $917K
Total Assets $780.6M $152.1M $94.64M $44.27M $18.35M
Other Current Liabilities $5.0K $13K -- -- --
Total Current Liabilities $9.88M $6.05M $3.63M $2.10M $1.64M
Total Non-Current Liabilities $188K $261K $578K $668K $0
Total Liabilities $10.07M $6.31M $4.21M $2.77M $1.64M
Total Debt (incl. Leases) $429K $537K $886K $866K --
Common Stock $4.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$185.3M -$107.6M -$71.50M -$39.87M -$27.22M
Accumulated Other Comp. Income -$536K -$660K -$374K -$392K -$196K
Total Stockholders' Equity $770.5M $145.8M $90.43M $41.50M -$15.09M
Total Equity $770.5M $145.8M $90.43M $41.50M -$15.09M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Cash & Cash Equivalents $352.9M $31.68M $88.16M $42.09M $17.34M
Short-Term Investments -- $4.55M -- -- --
Cash & Short-Term Investments $352.9M $36.23M $88.16M $42.09M $17.34M
Other Current Assets $5.0K -- -- -- --
Total Current Assets $494.3M $147.1M $89.94M $42.81M $17.43M
Property, Plant & Equipment, Net $344K $444K $490K $541K $94K
Intangible Assets $19K $31K -- -- --
Total Non-Current Assets $286.3M $5.06M $4.70M $1.47M $917K
Total Assets $780.6M $152.1M $94.64M $44.27M $18.35M
Other Current Liabilities $5.0K $13K -- -- --
Total Current Liabilities $9.88M $6.05M $3.63M $2.10M $1.64M
Total Non-Current Liabilities $188K $261K $578K $668K $0
Total Liabilities $10.07M $6.31M $4.21M $2.77M $1.64M
Total Debt (incl. Leases) $429K $537K $886K $866K --
Common Stock $4.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$185.3M -$107.6M -$71.50M -$39.87M -$27.22M
Accumulated Other Comp. Income -$536K -$660K -$374K -$392K -$196K
Total Stockholders' Equity $770.5M $145.8M $90.43M $41.50M -$15.09M
Total Equity $770.5M $145.8M $90.43M $41.50M -$15.09M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$77.61M -$36.14M -$31.63M -$12.65M -$9.67M -$5.75M
Depreciation & Amortization $184K $168K $139K $64K $30K $17K
Stock-Based Compensation $38.92M $8.99M $3.82M $1.48M $1.53M $1.36M
Operating Cash Flow -$36.99M -$29.23M -$29.84M -$11.46M -$7.47M -$4.44M
Capital Expenditure -$71K -$116K -$63K -$394K -$74K --
Free Cash Flow -$37.06M -$29.35M -$29.90M -$11.85M -$7.55M --
Purchases of Investments -- -$4.50M -- -- -- --
Sales & Maturities of Investments -- $77.84M -- -- -- --
Investing Cash Flow -$305.1M -$110.6M -$63K -$394K -$56K -$20K
Common Stock Issued -- -- -- -- -- $500K
Financing Cash Flow $663.2M $83.59M $75.96M $36.96M -$583K $28.06M
Net Change in Cash $321.3M -$56.48M $46.07M $24.75M -$8.27M $23.60M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for BLTE.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -10.1% -24.8% -35.0% -30.5% -- --
Return on Assets (ROA) -9.9% -23.8% -33.4% -28.6% -52.7% --
Current Ratio 50.02x 24.31x 24.76x 20.35x 10.66x --
Quick Ratio 35.71x 5.99x 24.27x 20.00x 10.61x --
Debt to Equity 0.00x 0.00x 0.01x 0.02x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for BLTE.
Source: SEC EDGAR CompanyFacts (CIK 0001889109) · from December 31, 2020 Data through December 31, 2025 · synced Nov 20, 2026, 05:14 UTC · Open in terminal